Biotech Campus Delft

What Biotech Campus Delft does

Biotech Campus Delft is a private open innovation campus located in Delft, Netherlands, owned by dsm-firmenich and positioning itself as the leading open innovation campus in Europe focused on biotechnology. The campus hosts approximately 1,200 professionals across 22 companies including dsm-firmenich's Taste, Texture & Health headquarters (operating from the Van Marken Food Innovation Center opened October 2025), Centrient Pharmaceuticals (sustainable enzymatic antibiotics and statins), Lesaffre (fermentation), and Plant One Delft (industrial-scale bioprocess piloting). Anchored by Planet B.io as the on-campus accelerator, the ecosystem also accommodates 20+ startups in industrial biotechnology, biomaterials, alternative proteins, and fermentation technology such as Foamlab, Paques Biomaterials (Caleyda PHA), Avansya (EverSweet), LanzaTech, and BioActa.

The campus traces its heritage to the 1869 Nederlandsche Gist- en Spiritusfabriek, evolving through Gist-Brocades and DSM into dsm-firmenich, with 150 years of fermentation expertise embedded in the site. Core infrastructure includes 14 hectares of campus land, a 5,000 m² pilot facility for industrial scale-up, shared laboratories, an Education Lab, and certified sustainable buildings (WELL Platinum, BREEAM Outstanding). The campus spans the full innovation cycle from research to pilot to production, with strategic partnerships with TU Delft, De Haagse Hogeschool, and regional government entities.

The business model operates as a real estate and ecosystem services platform: revenue is generated through renting facilities and laboratory spaces to biotech companies, providing shared infrastructure and accelerator services via Planet B.io, and hosting tenants ranging from global enterprises to early-stage startups. Long-term capital is anchored by ASR Dutch Science Park Fund's commitment of up to €500 million to expand the campus to 100,000 m² of leasable floor space by 2040, with dsm-firmenich retaining ownership of the land. The campus serves three primary segments: biotech startups and scale-ups, established biotech and pharma companies, and knowledge institutions, all focused on the transition to a sustainable, bio-based economy.

Name

Biotech Campus Delft

Legal name

Biotech Campus Delft

Website

https://biotechcampusdelft.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Biotech Campus Delft is a private open innovation campus in Delft, Netherlands, owned by dsm-firmenich, hosting 22 companies and ~1,200 professionals across industrial biotechnology, fermentation, and sustainable bio-based industries, with Planet B.io as its on-site accelerator and ASR Dutch Science Park Fund as a major capital partner.

Ownership category

akta.pro rank

Headquarters

HQ city

Delft

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Campus Real Estate and Ecosystem Services: The campus generates revenue through renting facilities and laboratory spaces to biotech companies, providing infrastructure and shared services to resident companies, and hosting the Planet B.io accelerator ecosystem.

Distribution channels2 records

Marketing channels3 records

Core offering

Biotech Campus Delft operates an open innovation campus that leases laboratory, pilot, and production facilities to biotech companies and provides shared infrastructure, accelerator services, and ecosystem support. The campus is anchored by Planet B.io, which accelerates industrial biotechnology startups and scale-ups, and supplemented by facilities such as Plant One Delft's Bioprocess Pilot Facility for industrial-scale testing. The core offering is real estate and ecosystem services for biotech tenants rather than a manufactured product.

Product overview

Biotech Campus Delft is an open innovation campus ecosystem rather than a single product. It comprises the campus infrastructure itself (Biotech Campus Delft), an accelerator program (Planet B.io) with shared lab facilities and an Education Lab, and numerous resident companies including major firms like dsm-firmenich Taste, Texture & Health and Centrient Pharmaceuticals, as well as 20+ startup residents under Planet B.io. The campus supports the entire innovation cycle from research and pilot to production, offering facilities including the Bioprocess Pilot Facility (Plant One Delft) for industrial scale-up testing. Resident companies focus on diverse areas including sustainable pharmaceuticals, food ingredients, biomaterials (Foamlab, Paques Biomaterials), alternative proteins, fermentation technology, and biotech tools.

Differentiator

Problem solved

Functional benefit

Brands

• Planet B.io: The accelerator for innovative biotech solutions located centrally at the Biotech Campus Delft, welcoming start-ups, scale-ups, and technical service providers active in industrial biotechnology.

Products and services

• Biotech Campus Delft An open innovation campus in Delft that leases laboratory, pilot, and production facilities to biotech startups, scale-ups, established companies, and knowledge institutions, supporting the full innovation cycle from research through pilot to production.
• Planet B.io Accelerator Accelerator program welcoming start-ups, scale-ups, and technical service providers active in industrial biotechnology, providing shared lab facilities, ecosystem support, access to campus infrastructure, and integration with the broader campus community.
• Plant One Delft Bioprocess Pilot Facility 5,000 m² pilot facility on campus where biotech companies can test, develop, and scale production processes from lab to industrial scale, with testing, filtration, separation, and drying services.
• Planet B.io Education Lab Educational facility designed to bring education and business together and promote practice-oriented learning for students and campus startups through programs like Pressure Cooker Weeks.
• Planet B.io Shared Lab Shared laboratory space available for lease on a flexible basis by educational institutions and local businesses, supporting proof-of-concept development for startups.

Quantifiable outcome

• 100,000 m² target leasable floor space by 2040
• +1 more outcomes

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core, moderate and minor.

• dsm-firmenichcoreStrategic or Co-development PartnerOwner of Biotech Campus Delft and primary tenant with Taste, Texture & Health headquarters. Opened Van Marken Food Innovation Center in October 2025. Historic connection dating back to 1869 as successor to Gist-Brocades.
• Planet B.iocoreStrategic or Co-development PartnerOn-campus accelerator for innovative biotech solutions. Manages startup ecosystem and has received over €1.5 million in subsidies for molecular biology lab, talent development, and Protein Port initiative. Also involved in European novel-food sandbox subsidy project.
• Plant One DelftcoreTechnology or IntegrationOwns and operates the 5,000 m² pilot facility for scaling biotech production processes. Companies can test if their innovative product is suitable for industrial-scale production at this facility.
• TU DelftmoderateStrategic or Co-development PartnerKnowledge institution collaborating with campus companies. Provides bioprocess technology courses and research partnerships with campus resident companies.
• De Haagse HogeschoolminorStrategic or Co-development PartnerEducational partnership for Pressure Cooker Week where students work on practical case studies for campus startups like DAB.bio and learn about biotechnology industry.

Scale indicators4 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• IndieBio: Biotech accelerator program supporting early-stage life science and industrial biology startups with lab facilities and seed funding — closely aligned with Planet B.io's startup support mission.
• LabCentral: Cambridge, MA-based biotech startup hub providing shared laboratory facilities and accelerator support to early-stage life science companies — a comparable shared-infrastructure incubator model.
• Francis Crick Institute: London-based biomedical research institute that hosts biotech collaborations and provides shared infrastructure for life science research — a comparable research-focused campus model with industry partnerships.
• BioInnovation Institute (BII): Copenhagen-based open innovation hub and accelerator for life science and biotech startups, sharing the same model of supporting early-stage ventures through lab facilities, mentorship, and ecosystem services.
• Cambridge Science Park: One of Europe's leading open innovation science parks, hosting a mix of startups, scale-ups, and established companies in life sciences and deep tech, comparable in scale and ecosystem positioning.
• Wageningen Campus: Dutch open innovation campus focused on food, nutrition, and bio-based sciences, with overlapping industrial biotech and circular economy focus and similar proximity to a major research university.

Broad incumbents

• Station F: Paris-based world's largest startup campus providing shared infrastructure to thousands of early-stage companies across multiple sectors, including biotech — comparable campus/incubator business model at much broader scale.
• MaRS Discovery District: Toronto-based urban innovation district hosting startups, corporates, and research institutions across health, biotech, and cleantech — comparable open-innovation campus model but broader in sector focus.
• JLABS (Johnson & Johnson Innovation): Global network of biotech incubators operated by J&J Innovation, offering similar lab infrastructure and tenant support for early-stage biotech companies but as part of a much larger corporate portfolio.
• Bayer CoLaborator: Bayer's external innovation hubs providing shared lab space for life science startups — analogous corporate-sponsored biotech incubator model, though anchored to a single corporate parent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/biotechdelft
• LinkedInlinkedin.com/company/biotech-campus-delft

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotech Campus Delft